Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & …, 2021 - Elsevier
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics.
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & …, 2021 - europepmc.org
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
Targeting Autophagy in Ischemic Stroke: From Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & … - digitalcommons.usf.edu
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & …, 2021 - pubmed.ncbi.nlm.nih.gov
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
[PDF][PDF] Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & …, 2021 - drive.google.com
Pharmacology & Therapeutics journal homepage: www. elsevier. com/locate/pharmthera s
University of Visayas, Gullas College of Medicine, Dionisio Jakosalem St, Cebu City, 6000 …
University of Visayas, Gullas College of Medicine, Dionisio Jakosalem St, Cebu City, 6000 …
Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology …, 2021 - augusta.elsevierpure.com
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology and …, 2021 - scholars.uthscsa.edu
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & …, 2021 - elibrary.ru
JR was supported by the National Key R&D Program of China (2017YFA0506000),
University of Wyoming Faculty Grant-in-Aid, Natural Science Foundation of China …
University of Wyoming Faculty Grant-in-Aid, Natural Science Foundation of China …
[HTML][HTML] Targeting Autophagy in Ischemic Stroke: From Molecular Mechanisms to Clinical Therapeutics
A Ajoolabady, S Wang, G Kroemer… - Pharmacology & …, 2021 - ncbi.nlm.nih.gov
Stroke constitutes the second leading cause of death and a major cause of disability
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …
worldwide. Stroke is normally classified as either ischemic or hemorrhagic stroke (HS) …